Layer‐Dependent Effect of Aβ‐Pathology on Cortical Microstructure With Ex Vivo Human Brain Diffusion MRI at 7 Tesla
Human Brain Mapping · 2025
DOI: 10.1002/hbm.70222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Brain Mapping, 2025. Verfasst von Zhiyong Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Alzheimer Disease, Cerebral Cortex, Tauopathies. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Department of Zhejiang Province, Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
The laminar‐specific distributions of Aβ and Tau deposition in the neocortex of Alzheimer's disease (AD) have been established. However, direct evidence about the effect of AD pathology on cortical microstructure is lacking in human studies. We performed high‐resolution T2‐weighted and diffusion‐weighted MRI (dMRI) on 15 ex vivo whole‐hemisphere specimens, including eight cases with low AD neuropathologic change, three cases with primary age‐related tauopathy (PART), and four healthy controls (HCs). Using the diffusion tensor model, we evaluated microstructure patterns in six layers of gray matter cortex and performed MRI‐histology correlation analysis across cortical layers. Aβ‐positive cases exhibited higher diffusivity than Aβ‐negative cases (PART and HC) in selected cortical regions, particularly in the inferior frontal cortex. Both Aβ/Tau depositions and dMRI‐based microstructural markers demonstrated distinct cortical layer‐dependent and region‐specific patterns. A significant positive correlation was observed between increased diffusivity and Aβ burden across six cortical layers but not with Tau burden. Furthermore, the mean diffusivity in layer V of the inferior frontal cortex significantly increased with the Amyloid stage. Our findings demonstrate a layer‐dependent effect of Aβ pathology on cortical microstructure of the human brain, which may be used to serve as a marker of low AD neuropathologic change.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
- Key Laboratory for Biomedical Engineering of Ministry of Education, Department of Biomedical Engineering, College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, China.
- National Human Brain Bank for Health and Disease, Zhejiang University, Hangzhou, China.
- Department of Pathology, The First Affiliated Hospital and School of Medicine, Zhejiang University, Hangzhou, China.
ORCID-Profile: Zhiyong Zhao, Dan Wu
Förderung
- National Natural Science Foundation of China
- Science and Technology Department of Zhejiang Province
- Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Zhao, Z., Cao, Z., Zhu, Q., Xu, H., Li, S., Zhu, L., Xu, G., Zhu, K., Zhang, J., & Wu, D. (2025). Layer‐Dependent Effect of Aβ‐Pathology on Cortical Microstructure With Ex Vivo Human Brain Diffusion MRI at 7 Tesla. Human Brain Mapping. https://doi.org/10.1002/hbm.70222
Vancouver
Zhao Z, Cao Z, Zhu Q, Xu H, Li S, Zhu L, et al. Layer‐Dependent Effect of Aβ‐Pathology on Cortical Microstructure With Ex Vivo Human Brain Diffusion MRI at 7 Tesla. Human Brain Mapping. 2025. doi:10.1002/hbm.70222
BibTeX
@article{Zhao2025,
author = {Zhao, Zhiyong and Cao, Zuozhen and Zhu, Qinfeng and Xu, Haoan and Li, Sihui and Zhu, Liangying and Xu, Guojun and Zhu, Keqing and Zhang, Jing and Wu, Dan},
title = {Layer‐Dependent Effect of Aβ‐Pathology on Cortical Microstructure With Ex Vivo Human Brain Diffusion MRI at 7 Tesla},
journal = {Human Brain Mapping},
year = {2025},
doi = {10.1002/hbm.70222}
}
EUVIMED